Molecule Details
| InChIKey | WMWTYOKRWGGJOA-CENSZEJFSA-N |
|---|---|
| Compound Name | Fluticasone Propionate |
| Canonical SMILES | CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.61 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00588 |
|---|---|
| Drug Name | Fluticasone propionate |
| CAS Number | 80474-14-2 |
| Groups | approved investigational |
| ATC Codes | nan |
| Description | Fluticasone propionate is a synthetic glucocorticoid[F4355,F4358][FDA Label]. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications[F4355,F4358][FDA Label]. Fluticasone propionate was first approved in 1990[L5962]. |
Categories: Adrenal Cortex Hormones Adrenals Agents to Treat Airway Disease Androstadienes Androstanes Androstenes Anti-Allergic Agents Anti-Asthmatic Agents Anti-Inflammatory Agents Autonomic Agents Bronchodilator Agents Central Nervous System Depressants Corticosteroids Corticosteroids, Dermatological Preparations Corticosteroids, Potent (Group III) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (strong) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inhibitors Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dermatologicals Fused-Ring Compounds Glucocorticoids Immunosuppressive Agents OATP1B1/SLCO1B1 Inhibitors P-glycoprotein substrates Peripheral Nervous System Agents Respiratory System Agents Steroids Thyroxine-binding globulin inhibitors
Cross-references: BindingDB: 50354849 ChEBI: 31441 CHEMBL1473 ChemSpider: 392059 Drugs Product Database (DPD): 637 D01708 PharmGKB: PA449686 PubChem:444036 PubChem:46506140 RxCUI: 50121 Therapeutic Targets Database: DAP001039 Wikipedia: Fluticasone_propionate ZINC: ZINC000003920027
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P04150 | NR3C1 | Homo sapiens | Human | PF02155 PF00104 PF00105 | 10.1 | IC50 | ChEMBL;BindingDB |
| Q99576 | TSC22D3 | Homo sapiens | Human | PF01166 | 9.8 | IC50 | BindingDB |
| P06401 | PGR | Homo sapiens | Human | PF00104 PF02161 PF00105 | 7.7 | IC50 | ChEMBL;BindingDB |
| P08235 | NR3C2 | Homo sapiens | Human | PF00104 PF00105 | 6.8 | IC50 | ChEMBL;BindingDB |
DrugBank Target Actions (14)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08185 | SERPINA6 | Corticosteroid-binding globulin | binder | carriers |
| Q9Y6L6 | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | inhibitor | carriers |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P10632 | CYP2C8 | Cytochrome P450 2C8 | inhibitor | enzymes |
| P20815 | CYP3A5 | Cytochrome P450 3A5 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P20815 | CYP3A5 | Cytochrome P450 3A5 | substrate | enzymes |
| P24462 | CYP3A7 | Cytochrome P450 3A7 | substrate | enzymes |
| P04150 | NR3C1 | Glucocorticoid receptor | agonist | targets |
| P06401 | PGR | Progesterone receptor | agonist | targets |
| P08235 | NR3C2 | Mineralocorticoid receptor | antagonist | targets |
| P47712 | PLA2G4A | Cytosolic phospholipase A2 | inhibitor | targets |
| Q9Y6L6 | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | inhibitor | transporters |
| P08183 | ABCB1 | ATP-dependent translocase ABCB1 | substrate | transporters |